Search Results 11-20 of 15765 for Residual
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Relapse in Aggressive B-cell Non-Hodgkin Lymphomas · Overview · Participation eligibility.
Mylan Blomquist, M.D.-Ph.D. student at Mayo Clinic, is researching the imaging of residual brain tumor cells to improve glioblastoma treatment.
About this study. The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in ...
The primary objective of this study is to determine the hearing preservation advantage, defined as the increased chance of preservation of residual hearing ...
To access residual muscle specimens from diagnostic muscle biopsies obtained as part of the routine medical care. The biospecimens will be used to better ...
Effect of Prolonged Fasting Time on Gastric Residual Volume in Patients Taking GLP1 Receptor Agonists · Overview · Participation eligibility · Participating Mayo ...
The purpsoe of this study is to determine the feasibility of transitioning patients with brain tumors from one candidate senolytic therapy to the next in a ...
About this study. To assess the response of persistent Barrett's Esophagus and/or dysplasia to focal cyro ablation .
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Study of Residual Insulin (C-Peptide) Secretion · Overview · Participation eligibility · Participating Mayo Clinic locations · More information · Additional contact ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.